KST-016366

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameKST-016366
Drug Alias NameKST-016366
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNerve growth factor receptor Trk-A antagonists +[2] 
TargetsTEK receptor tyrosine kinaseNerve growth factor receptor Trk-A
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKorea Institute Of Science And Technology
China Registration ClassN/A

Develop Information

Active CompaniesKorea Institute Of Science And Technology
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A